You can find more information about PF3D7_0312400-GSK-3b using the following links:

PlasmoDB - the Plasmodium genome resource
The TDR Targets Database

Subcellular Localization

Affecting Drugs
Drug Name PubMed Articles (year of publication)
3,6-diamino-4-(2-bromophenyl)-2-(3,4-dichlorobenzoyl)thieno[2,3-b]pyridine-5-carbonitrile
3,6-diamino-4-(2-bromophenyl)-2-(3-chlorobenzoyl)thieno[2,3-b]pyridine-5-carbonitrile
3,6-diamino-4-(2-halophenyl)-2-benzoylthieno[2,3-b]pyridine-5-carbonitriles
3,6-diamino-4-(thiophen-2-yl)thieno[2,3-b]pyridine-2,5-dicarbonitrile‚Äč
3,6-diamino-4-o-tolylthieno[2,3-b]pyridine-2,5-dicarbonitrile
4-((5-Chloro-4-(5-methylthiophen-2-yl)pyrimidin-2-yl)amino)-N- (3-morpholinopropyl)benzamide (23f)
4-[(6-methoxy-1-benzofuran-2-yl)carbonyl]benzonitrile
4-phenylthieno[2,3-b]pyridine
Actinomyces strain FH025
Actinomyces strain H11809
Curcumin
In silico, suggested target
indirubin-30-monoxime
Indirubins
Manzamine a
Meridians
Paullone
Quinazolinone
Structure-based design, suggested target